UK Markets close in 6 hrs 40 mins
  • FTSE 100

    7,475.91
    +6.13 (+0.08%)
     
  • FTSE 250

    21,721.09
    -151.99 (-0.69%)
     
  • AIM

    1,085.12
    -12.17 (-1.11%)
     
  • GBP/EUR

    1.1986
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.3429
    -0.0034 (-0.2525%)
     
  • BTC-GBP

    27,235.97
    -1,046.35 (-3.70%)
     
  • CMC Crypto 200

    834.46
    -21.35 (-2.49%)
     
  • S&P 500

    4,349.93
    -6.52 (-0.15%)
     
  • DOW

    34,168.09
    -129.61 (-0.38%)
     
  • CRUDE OIL

    87.13
    -0.22 (-0.25%)
     
  • GOLD FUTURES

    1,814.00
    -15.70 (-0.86%)
     
  • NIKKEI 225

    26,170.30
    -841.00 (-3.11%)
     
  • HANG SENG

    23,807.00
    -482.90 (-1.99%)
     
  • DAX

    15,342.07
    -117.32 (-0.76%)
     
  • CAC 40

    6,956.57
    -25.39 (-0.36%)
     

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

·9-min read

Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech

05-Jan-2022 / 14:31 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

 

 

Aubagne, January 5, 2022

 

Half-year liquidity contract statement for Sartorius Stedim Biotech

 

Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on December 31st 2021:

 

 

As a reminder :

 

the following resources appeared on the last half year statement on 30 June 2021 on the liquidity account:

 

 

 

 

 

the following resources appeared on the liquidity account when the activity started:

 

 

 

 

 

 

The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June

22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.

A profile of Sartorius Stedim Biotech

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2020, the company employed more than 7,500 people, and earned sales revenue of 1,910 million euros.

 

Contact

Petra Kirchhoff

Head of Corporate Communications & Investor Relations

+49 (0)551.308.1686

Petra.kirchhoff@sartorius.com

 

Sartorius Stedim Biotech S.A.

Z.I. Les Paluds

Avenue de Jouques, CS 91051

13781 Aubagne Cedex, France

Phone: +33.(0)4.42.84.56.00

Fax: +33.(0)4.42.84.56.19

www.sartorius-stedim.com

 

 

 

APPENDIX H2 2021

 

 

Buy side

Sell side

 

Number of executions

Number of shares

Traded volume in EUR

Number of executions

Number of shares

Traded volume in EUR

TOTAL

2,810

95,701

44,247,756.63

2,600

94,714

45,073,166.52

01/07/2021

52

2,000

790,040.00

11

300

120,741.00

02/07/2021

4

300

118,200.00

20

500

198,220.00

05/07/2021

11

400

157,400.00

6

104

41,275.52

06/07/2021

-

-

-

51

2,096

859,234.24

07/07/2021

-

-

-

26

1,100

467,203.00

08/07/2021

-

-

-

9

400

175,200.00

09/07/2021

41

1,300

563,784.00

-

-

-

12/07/2021

-

-

-

45

1,100

485,100.00

13/07/2021

13

600

262,422.00

7

300

133,860.00

14/07/2021

1

51

22,593.00

4

300

134,700.00

16/07/2021

-

-

-

9

200

91,900.00

19/07/2021

42

1,349

613,646.61

4

100

46,250.00

20/07/2021

35

1,900

857,451.00

-

-

-

21/07/2021

143

5,996

2,620,431.88

32

1,009

458,802.39

22/07/2021

16

500

218,000.00

82

2,091

938,900.82

23/07/2021

1

100

45,600.00

38

1,175

542,732.50

26/07/2021

21

900

413,091.00

20

625

291,443.75

27/07/2021

10

400

181,772.00

20

800

368,400.00

28/07/2021

3

200

92,300.00

34

1,000

468,500.00

29/07/2021

11

400

187,400.00

7

200

94,700.00

30/07/2021

11

400

187,600.00

31

1,400

671,300.00

02/08/2021

10

500

239,500.00

15

400

193,400.00

03/08/2021

2

100

48,300.00

11

500

243,620.00

04/08/2021

6

100

48,300.00

14

500

246,000.00

05/08/2021

-

-

-

22

600

297,300.00

06/08/2021

52

1,600

776,800.00

-

-

-

09/08/2021

-

-

-

18

500

244,000.00

10/08/2021

1

100

49,000.00

30

856

423,035.20

11/08/2021

15

600

291,900.00

-

-

-

12/08/2021

18

701

336,472.99

4

144

69,651.36

13/08/2021

2

199

94,923.00

-

-

-

16/08/2021

14

200

95,100.00

5

300

144,600.00

17/08/2021

-

-

-

40

1,700

835,992.00

18/08/2021

-

-

-

26

1,000

504,500.00

19/08/2021

67

1,900

935,351.00

19

600

296,442.00

20/08/2021

5

100

50,000.00

42

1,500

755,595.00

23/08/2021

-

-

-

5

200

103,300.00

24/08/2021

-

-

-

1

100

52,000.00

25/08/2021

-

-

-

1

100

52,500.00

31/08/2021

-

-

-

4

100

53,060.00

20/09/2021

98

1,200

596,700.00

4

400

208,200.00

21/09/2021

-

-

-

36

800

423,384.00

23/09/2021

-

-

-

4

200

107,600.00

27/09/2021

120

3,500

1,722,770.00

-

-

-

28/09/2021

146

3,614

1,708,265.52

-

-

-

29/09/2021

-

-

-

113

3,200

1,556,512.00

30/09/2021

-

-

-

4

200

98,500.00

01/10/2021

125

5,000

2,309,750.00

9

400

189,200.00

04/10/2021

125

5,491

2,416,534.19

1

100

45,200.00

05/10/2021

7

100

43,540.00

82

3,300

1,479,258.00

06/10/2021

39

1,400

620,704.00

-

-

-

07/10/2021

50

2,200

968,990.00

44

851

380,082.13

08/10/2021

17

700

305,900.00

17

749

331,597.28

11/10/2021

35

1,000

429,500.00

6

300

129,600.00

12/10/2021

10

200

85,800.00

49

2,104

924,729.04

13/10/2021

-

-

-

110

3,596

1,628,700.32

 

Buy side

Sell side

 

Number of executions

Number of shares

Traded volume in EUR

Number of executions

Number of shares

Traded volume in EUR

14/10/2021

1

100

45,660.00

53

2,000

933,460.00

15/10/2021

10

400

186,200.00

37

600

283,002.00

18/10/2021

24

700

324,618.00

8

400

187,860.00

19/10/2021

26

1,200

560,400.00

35

1,100

523,699.00

20/10/2021

99

3,200

1,467,872.00

27

3,200

1,498,272.00

21/10/2021

1

100

46,900.00

36

2,000

959,000.00

22/10/2021

8

500

239,500.00

52

600

291,900.00

25/10/2021

-

-

-

26

700

338,338.00

26/10/2021

48

1,900

901,987.00

34

1,100

528,902.00

27/10/2021

60

2,516

1,189,439.00

10

600

288,900.00

28/10/2021

12

384

180,311.04

19

800

380,400.00

29/10/2021

2

100

47,100.00

-

-

-

01/11/2021

-

-

-

23

1,100

533,500.00

02/11/2021

5

200

96,300.00

14

700

344,400.00

03/11/2021

-

-

-

6

200

99,300.00

04/11/2021

2

100

49,300.00

15

400

199,800.00

05/11/2021

218

5,200

2,432,092.00

-

-

-

08/11/2021

-

-

-

38

2,800

1,318,212.00

09/11/2021

18

400

186,940.00

21

600

283,500.00

10/11/2021

69

4,000

1,830,200.00

2

11

5,071.00

11/11/2021

12

300

136,101.00

19

789

364,731.03

12/11/2021

-

-

-

20

1,000

470,500.00

15/11/2021

8

200

94,700.00

22

800

382,000.00

16/11/2021

18

800

378,200.00

4

100

47,800.00

17/11/2021

8

300

142,200.00

38

1,300

626,197.00

18/11/2021

16

505

243,697.85

15

700

338,898.00

19/11/2021

-

-

-

116

5,200

2,577,380.00

22/11/2021

12

700

345,499.00

12

400

204,600.00

23/11/2021

212

6,295

2,979,990.05

20

500

239,500.00

24/11/2021

29

1,106

518,183.12

20

1,200

567,936.00

25/11/2021

-

-

-

56

1,700

817,666.00

26/11/2021

17

400

191,100.00

128

4,305

2,161,239.15

29/11/2021

37

1,100

561,000.00

47

895

468,980.00

30/11/2021

-

-

-

83

3,045

1,609,982.85

01/12/2021

12

300

149,100.00

-

-

-

02/12/2021

79

2,300

1,124,700.00

-

-

-

03/12/2021

18

800

386,784.00

22

1,000

495,500.00

06/12/2021

125

5,194

2,414,015.38

-

-

-

07/12/2021

-

-

-

103

4,169

1,985,027.66

08/12/2021

2

100

47,700.00

48

1,900

931,304.00

09/12/2021

8

200

95,500.00

-

-

-

10/12/2021

28

1,300

614,796.00

-

-

-

13/12/2021

13

500

233,000.00

-

-

-

14/12/2021

63

1,600

728,800.00

-

-

-

15/12/2021

-

-

-

22

800

373,200.00

16/12/2021

13

500

231,500.00

22

1,000

477,600.00

17/12/2021

19

700

319,900.00

-

-

-

20/12/2021

31

600

272,358.00

19

604

284,085.36

21/12/2021

16

700

319,403.00

32

596

277,044.64

22/12/2021

6

200

91,500.00

17

1,000

465,540.00

23/12/2021

5

100

46,300.00

3

200

94,100.00

24/12/2021

-

-

-

3

100

47,100.00

27/12/2021

-

-

-

22

932

443,790.44

28/12/2021

-

-

-

8

368

177,607.84

29/12/2021

-

-

-

9

200

97,400.00

30/12/2021

-

-

-

19

700

343,819.00

31/12/2021

21

600

291,078.00

3

200

99,100.00

 

 

Regulatory filing PDF file

File: Half-year liquidity contract statement for Sartorius Stedim Biotech


Language:

English

Company:

Sartorius Stedim Biotech SA

Avenue de Jouques

13781 Aubagne

France

Phone:

+33 44 284 5600

E-mail:

info@sartorius-stedim.com

Internet:

www.sartorius-stedim.com

ISIN:

FR0013154002

Euronext Ticker:

DIM

AMF Category:

Share buyback / Disposal of own shares / Information relating to the liquidity contract

EQS News ID:

1265187

 

End of Announcement

EQS News Service

show this
show this
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting